Noninvasive, Targeted, and Non-Viral Ultrasound-Mediated GDNF-Plasmid Delivery for Treatment of Parkinson's Disease

Scientific Reports
Ching-Hsiang FanChih-Kuang Yeh

Abstract

Glial cell line-derived neurotrophic factor (GDNF) supports the growth and survival of dopaminergic neurons. CNS gene delivery currently relies on invasive intracerebral injection to transit the blood-brain barrier. Non-viral gene delivery via systematic transvascular route is an attractive alternative because it is non-invasive, but a high-yield and targeted gene-expressed method is still lacking. In this study, we propose a novel non-viral gene delivery approach to achieve targeted gene transfection. Cationic microbubbles as gene carriers were developed to allow the stable formation of a bubble-GDNF gene complex, and transcranial focused ultrasound (FUS) exposure concurrently interacting with the bubble-gene complex allowed transient gene permeation and induced local GDNF expression. We demonstrate that the focused ultrasound-triggered GDNFp-loaded cationic microbubbles platform can achieve non-viral targeted gene delivery via a noninvasive administration route, outperform intracerebral injection in terms of targeted GDNF delivery of high-titer GDNF genes, and has a neuroprotection effect in Parkinson's disease (PD) animal models to successfully block PD syndrome progression and to restore behavioral function. This study expl...Continue Reading

References

Mar 21, 1996·Nature·D M GashG A Gerhardt
Feb 6, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·O RascolF Stocchi
Aug 18, 2004·Ultrasound in Medicine & Biology·Nickolai SheikovKullervo Hynynen
Oct 16, 2004·The Journal of Biological Chemistry·Shaoxia ZhouMax G Bachem
Aug 9, 2006·Langmuir : the ACS Journal of Surfaces and Colloids·Ine LentackerNiek N Sanders
Apr 11, 2007·Bioconjugate Chemistry·Sophie Mehier-HumbertThierry Bettinger
Jun 15, 2007·Ultrasound in Medicine & Biology·Feng-Yi YangWin-Li Lin
Jul 1, 2008·Progress in Neurobiology·Tomas DeierborgPatrik Brundin
Aug 8, 2009·Progress in Brain Research·Shilpa RamaswamyJeffrey H Kordower
Nov 20, 2009·International Journal of Pharmaceutics·Cai-Xia HeJian-Qing Gao
Dec 17, 2009·The Journal of the Acoustical Society of America·Feng-Yi YangChi-Hong Chang
Mar 31, 2010·Proceedings of the Institution of Mechanical Engineers. Part H, Journal of Engineering in Medicine·H-D LiangM Halliwell
Jun 4, 2010·The New England Journal of Medicine·Kenneth A FollettUNKNOWN CSP 468 Study Group
Nov 13, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Feng-Yi YangTai-Kuang Chao
Mar 17, 2011·Physical Review Letters·Hong ChenThomas J Matula
Aug 6, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·D Eugene RedmondJohn R Sladek
Jul 16, 2014·Ultrasound in Medicine & Biology·I-Chi LeeYing-Chih Chang
Jan 15, 2015·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Gesthimani SamiotakiElisa E Konofagou
Mar 13, 2015·Science Translational Medicine·Gerhard Leinenga, Jürgen Götz
Mar 21, 2015·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·O van TellingenH E de Vries
Jun 15, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Chung-Yin LinHao-Li Liu

❮ Previous
Next ❯

Citations

Apr 12, 2017·Topics in Current Chemistry·Yifei Lu, Chen Jiang
May 17, 2017·Current Opinion in Neurology·Alfonso FasanoEsther Cubo
Feb 25, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Ying MengNir Lipsman
Jun 16, 2017·Journal of Central Nervous System Disease·Paul S Fishman, Victor Frenkel
Sep 29, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Kristiana XhimaAnurag Tandon
Apr 17, 2018·Journal of Drug Targeting·Chaopin YangZhiyi Chen
Jul 31, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Maria Eleni KarakatsaniElisa Evgenia Konofagou
Jul 3, 2020·Chemical & Pharmaceutical Bulletin·Koki OgawaShigeru Kawakami
Feb 26, 2019·Frontiers in Cellular Neuroscience·Xuan HeYongfang Zhang
Jul 19, 2017·Journal of Therapeutic Ultrasound·Paul S Fishman
May 7, 2019·Frontiers in Pharmacology·Chaopin YangZhiyi Chen
Nov 30, 2018·Bulletin of Experimental Biology and Medicine·T A MishchenkoM B Vedunova
Sep 21, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Paul Fishman, Nir Lipsman
Mar 1, 2017·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Paul S Fishman, Victor Frenkel
Oct 17, 2017·Journal of Therapeutic Ultrasound·Ying MengNir Lipsman
Oct 18, 2020·Pharmaceutics·Yoko Endo-Takahashi, Yoichi Negishi
Dec 19, 2020·Pharmaceutics·Seigo Kimura, Hideyoshi Harashima
Jul 22, 2019·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ying MengNir Lipsman
Oct 28, 2020·Nature Reviews. Neurology·Ying MengNir Lipsman
Apr 4, 2021·International Journal of Molecular Sciences·Youngpyo NamSang Ryong Kim
Apr 27, 2021·Journal of Parkinson's Disease·Sarah JarrinEilís Dowd
Jul 24, 2021·Cellular and Molecular Life Sciences : CMLS·Yi-Ju HoChih-Kuang Yeh
Aug 20, 2021·Journal of Neuro-oncology·Michael ZhangGordon Li
Dec 12, 2018·Langmuir : the ACS Journal of Surfaces and Colloids·Jean-Michel Escoffre, Ayache Bouakaz
Oct 12, 2021·Frontiers in Neuroscience·Jonathan M Fischell, Paul S Fishman
Dec 7, 2021·Regenerative Medicine·Milad RoshaniRouhollah Mehdinavaz Aghdam

❮ Previous
Next ❯

Methods Mentioned

BETA
fluorescence imaging
transfection
ELISA
Fluorescence

Software Mentioned

ImageJ
Living Image

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Astrocytes in Parkinson Disease

Parkinson's disease (PD) is a neurodegenerative disorder caused by the progressive loss of dopaminergic neurons. Some PD-genes may be associated with astrocyte dysfunction. Discover the latest research on astrocytes in Parkinson's disease here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.